Geode Capital Management
CADL icon

Geode Capital Management’s Candel Therapeutics CADL Stock Holding History

Geode Capital Management’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.07M Buy
1,035,435
+57,923
+6% +$315K ﹤0.01% 2732
2025
Q4 		$5.52M Buy
977,512
+49,315
+5% +$265K ﹤0.01% 2713
2025
Q3 		$4.73M Buy
928,197
+24,227
+3% +$140K ﹤0.01% 2811
2025
Q2 		$4.57M Buy
903,970
+216,509
+31% +$1.11M ﹤0.01% 2771
2025
Q1 		$3.89M Buy
687,461
+232,037
+51% +$1.9M ﹤0.01% 2767
2024
Q4 		$3.95M Buy
455,424
+6,427
+1% +$38K ﹤0.01% 2855
2024
Q3 		$3.11M Buy
448,997
+51,111
+13% +$318K ﹤0.01% 2970
2024
Q2 		$2.47M Buy
397,886
+252,180
+173% +$1.89M ﹤0.01% 3063
2024
Q1 		$230K Buy
145,706
+6,453
+5% +$9.58K ﹤0.01% 3895
2023
Q4 		$205K Hold
139,253
– – ﹤0.01% 3934
2023
Q3 		$130K Buy
139,253
+8,050
+6% +$9.3K ﹤0.01% 4158
2023
Q2 		$165K Hold
131,203
– – ﹤0.01% 4125
2023
Q1 		$180K Hold
131,203
– – ﹤0.01% 4103
2022
Q4 		$234K Buy
131,203
+2,357
+2% +$4.67K ﹤0.01% 4010
2022
Q3 		$404K Buy
128,846
+53,629
+71% +$182K ﹤0.01% 3838
2022
Q2 		$243K Hold
75,217
– – ﹤0.01% 4145
2022
Q1 		$382K Buy
75,217
+16,932
+29% +$84.1K ﹤0.01% 4075
2021
Q4 		$455K Buy
58,285
+37,890
+186% +$368K ﹤0.01% 4106
2021
Q3 		$221K Buy
+20,395
New +$169K ﹤0.01% 4410

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return

Geode Capital Management's CADL Position: Q1 2026 in Review

Geode Capital Management increased its Candel Therapeutics (CADL) stake by 5.9% in Q1 2026, buying an estimated $315K and bringing the position to 1,035,435 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

Geode Capital Management first reported a position in CADL in Q3 2021 and has held it in 19 quarters since. The position peaked at $5.52M in Q4 2025. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • Geode Capital Management held 1,035,435 shares of Candel Therapeutics worth $5.07M as of Q1 2026.
  • Geode Capital Management bought 57,923 Candel Therapeutics shares in Q1 2026, an estimated $315K.
  • Candel Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2732 holding.
  • Geode Capital Management first reported a position in Candel Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Geode Capital Management's Candel Therapeutics position peaked at $5.52M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.